We are building this new website to better deliver information. Find out more. We are building this new website to better deliver information. Find out more.
Let us know what you think.

Updates on 27/09/2021

Rabies and other lyssaviruses

Recommendations have been updated to allow intradermal vaccination and accelerated schedules for rabies pre-exposure prophylaxis.

Recommendations for people at ongoing exposure risk in selected high-risk occupations have been updated to specify a booster dose 1 year after completing the 1st course of pre-exposure prophylaxis, and every 3 years after that.

For post-exposure prophylaxis, recommendations have been updated to specify the number of vaccine doses and the need for human rabies immunoglobulin for people who are mildly immunocompromised and people who are severely immunocompromised.